Synaptic dysregulation in a mouse model of GRIN2D developmental and epileptic encephalopathy
Brain · 04.11.2025 · 148 (11) · 3973-3988
DOI: 10.1093/brain/awaf125 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain, online erschienen am 09.04.2025. Verfasst von JiaJie Teoh und 27 weiteren Autor:innen. Beteiligte Einrichtung: Center for Translational Research in Neurodevelopmental Disease in the Department of Neurology, Columbia University Irving Medical Center, New York, …. Hauptthemen laut MEDLINE: Receptors, N-Methyl-D-Aspartate, Synapses, Epilepsy. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, NICHD NIH HHS, NIMH NIH HHS.
Abstract (Originalsprache)
Gain-of-function (GoF) variants in the GRIN2D gene, encoding the GluN2D subunit of the N-methyl-D-aspartate receptor (NMDAR), cause a severe developmental and epileptic encephalopathy (DEE) characterized by intractable seizures, hypotonia and neurodevelopmental delay. We generated mice carrying the GoF V664I variant, orthologous to V667I, which is present in ∼25% of GRIN2D-DEE patients. Heterozygous mutant mice demonstrate behavioural, neuroanatomical and electrophysiological abnormalities. Lethal convulsive seizures are observed beginning at postnatal Day 17. As adults, heterozygotes display abundant and prolonged runs of spike-wave discharges (SWD) that often persist for minutes. The SWD epochs consist of different populations, differentiated by frequency and association with time-locked behavioural arrest. V664I mutant neurons have enlarged presynaptic terminals and increased synaptic distance. Functional analysis reveals increased inhibitory synaptic activity without changes in NMDAR decay kinetics or presynaptic plasticity in CA1 neurons, and analysis of hippocampal local field potentials shows a 1.5-fold increase in evoked responses and a 1.7-fold increase in action potential generation. Notably, expression of V664I in GABAergic interneurons, but not excitatory forebrain neurons, is sufficient to recapitulate the severe electroclinical phenotype. Altogether, our studies show that altered NMDAR function in inhibitory neurons plays a prominent role in DEE associated with GRIN2D GoF variants, suggesting that targeted genetic treatment may represent a path forward to successful therapeutic intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Translational Research in Neurodevelopmental Disease in the Department of Neurology, Columbia University Irving Medical Center, New York, NY 10032, USA.
- Department of Neurology, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY 10032, USA.
- Department of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, GA 30322, USA.
- Department of Neuroscience, Columbia University, New York, NY 10032, USA.
- Department of Genetics and Development, Columbia University Irving Medical Center, New York, NY 10032, USA.
- Center for Gene Therapy, The Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH 43205, USA.
ORCID-Profile: Aamir Zuberi, Moran Rubinstein, Moran Hausman-Kedem, Hongjie Yuan, Stephen F Traynelis
Förderung
- NIH HHS
- NICHD NIH HHS
- NIMH NIH HHS
- NIA NIH HHS
- NCI Cancer Center Support
- NINDS NIH HHS
- National Science Foundation Graduate Research Fellowships Program
- Simon's Foundation
Zitieren
APA
Teoh, J., Simko, J., Camp, C. R., Liu, C. J., Wang, W., Williams, D. J., Ma, L., Soundararajan, D., Martin, C., Taylor, N. K., François, E., Petri, S., Kanber, A., Ravichandra, A., Pero, M. E., Bartolini, F., Swayne, T. C., Lutz, C. M., Zuberi, A., …, & Frankel, W. N. (2025). Synaptic dysregulation in a mouse model of GRIN2D developmental and epileptic encephalopathy. Brain, 148(11), 3973-3988. https://doi.org/10.1093/brain/awaf125
Vancouver
Teoh J, Simko J, Camp CR, Liu CJ, Wang W, Williams DJ, et al. Synaptic dysregulation in a mouse model of GRIN2D developmental and epileptic encephalopathy. Brain. 2025;148(11):3973-3988. doi:10.1093/brain/awaf125
BibTeX
@article{Teoh2025,
author = {Teoh, JiaJie and Simko, Jane and Camp, Chad R and Liu, Christine J and Wang, Wanqi and Williams, Damian J and Ma, Liang and Soundararajan, Divyalakshmi and Martin, Caryn and Taylor, Noah K and François, Ekniel and Petri, Sabrina and Kanber, Ayla and Ravichandra, Aishwarya and Pero, Maria Elena and Bartolini, Francesca and Swayne, Theresa C and Lutz, Cathleen M and Zuberi, Aamir and Rubinstein, Moran and Hausman-Kedem, Moran and Yuan, Hongjie and Gelinas, Jennifer N and Sands, Tristan T and Harper, Scott Q and Traynelis, Stephen F and Makinson, Christopher D and Frankel, Wayne N},
title = {Synaptic dysregulation in a mouse model of GRIN2D developmental and epileptic encephalopathy},
journal = {Brain},
year = {2025},
volume = {148},
number = {11},
pages = {3973--3988},
doi = {10.1093/brain/awaf125}
}
EUVIMED